Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA

RNA

Volumn 2, Issue 5, 1996, Pages 419-428

  Jarvis, Thale C ^a   Alby, Laverna J ^a   Beaudry, Amber A ^a   Wincott, Francine E ^a   Beigelman, Leonid ^a   McSwiggen, James A ^a   Usman, Nassim ^a   Stinchcomb, Dan T ^a  

^a Sirna Therapeutics Inc   (United States)

Author keywords

antisense; c myb; cell proliferation; restenosis; ribozymes; smooth muscle cells

Indexed keywords

RIBOZYME;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; FEMALE; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; RAT; RNA ANALYSIS; RNA CLEAVAGE; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NUCLEIC ACID CONFORMATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; RATS; RATS, SPRAGUE-DAWLEY; RNA, CATALYTIC; RNA, MESSENGER; SWINE; TRANS-ACTIVATORS;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0029959522     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alitalo K, Winquist R, Linn CC, de la Chapelle A, Schwab M, Bishop JM. 1984. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci USA 51:4534-4538.
2. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. 1985. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 6:369-375.
3. Beigelman L, McSwiggen J, Draper K, Gonzalez C, Jensen K, Karpeisky A, Modak A, Matulic-Adamic J, DiRenzo A, Haeberli P, Sweedler D, Tracz D, Grimm S, Wincott F, Thackray V, Usman N. 1995. Chemical modification of ribozymes: Catalytic activity and nuclease resistance. J Biol Chem 270:25702-25708.
4. Biro S, Fu YM, Yu ZX, Epstein SE. 1993. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 90:654-658.
5. Brown KE, Kindy MS, Sonenshein GE. 1992. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem 267:4625-4630.
6. Burgess T, Fisher E, Ross S, Bready J, Qian YX, Bayewitch L, Cohen A, Herrara C, Hu S, Kramer T, Lott F, Martin F, Pierce G, Simonet L, Farrell C. 1995. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci USA 92:4051-4055.
7. Cech TR. 1992. Ribozyme engineering. Curr Opin Struct Biol 2:605-609.
8. Chang M, Barr E, Seltzer J, Jiang YQ, Nabel G, Nabel E, Parmacek M, Leiden J. 1995. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518-522.
9. Christofferson R, Marr J. 1995. Ribozymes as human therapeutic agents. J Med Chem 35:2023-2037.
10. Clarke FF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EU. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8:884-892.
11. Epstein SE, Speir E, Finkel T. 1993. Do antisense approaches to the problem of restenosis make sense? Circulation 53:1351-1353.
12. Forrester JS, Fishbein M, Helfant R, Fagin J. 1991. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol 17:758-769.
13. Garratt KN, Edwards WD, Kaufmann UP, Vlietstra RE, Holmes DRJ. 1991. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 17:442-428.
14. Griffin CA, Baylin SB. 1985. Expression of the c-myb oncogene in human small lung carcinoma. Cancer Res 45:272-275.
15. Guzman LA, Garrel CL, Poptic EJ, DiCorleto PE, Topol EJ. 1994. Despite in vivo cellular and nuclear uptake, antisense oligonucleotides do not have a significant anti-proliferative effect after vascular injury. Circulation 90:1-47.